Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures. [NA]
This clinical trial update reports the completion of a study evaluating probe-based and needle-based confocal laser endomicroscopy during gy…
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Efficacy and Safety of Apatinib As Third Line Therapy in Patients With Advanced Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating apatinib as a third-line therapy for advanced ovarian cancer, focusing on efficacy and safety. The update …
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy [Phase 2]
This Phase 2 trial evaluated the combination of sargramostim with paclitaxel albumin-stabilized nanoparticle formulation in patients with ad…
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC) [Phase 2]
A Phase 2 study comparing DNIB0600A to pegylated liposomal doxorubicin in platinum-resistant ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Phase I Platinum Based Chemotherapy Plus Indomethacin [Phase 1]
Phase I study of platinum-based chemotherapy in combination with indomethacin for colorectal, esophageal, and ovarian cancers has completed.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer [Phase 1]
This Phase 1 trial update reports results for a NY-ESO-1 vaccine with the GLA-SE adjuvant in patients with unresectable or metastatic cancer…
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: TIL Therapy for Metastatic Ovarian Cancer [Phase 1]
Phase 1 clinical trial update of tumor-infiltrating lymphocyte (TIL) therapy for metastatic ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer [Phase 2]
Phase 2 clinical trial comparing intraperitoneal versus intravenous chemotherapy after neoadjuvant treatment in ovarian cancer has completed…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification [NA]
A completed clinical trial evaluating whether altering dietary macronutrient intake can disrupt cancer metabolism and growth in ovarian and …
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer
This clinical trial update reports the results of a completed study evaluating bevacizumab in combination with front-line chemotherapy for o…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating a combination chemotherapy regimen with peripheral stem cell transplantation for stage III ovarian cancer has bee…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Role of Intraperitoneal Intraoperative Chemotherapy With Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis From Ovarian Cancer. Hyperthermia Versus Normothermia [Phase 2]
Completed Phase 2 trial evaluating intraperitoneal intraoperative paclitaxel chemotherapy for peritoneal carcinomatosis from ovarian cancer,…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer [Phase 1]
A completed Phase 1 trial evaluating the safety of combining SB-485232 (interleukin-18) with Doxil (liposomal doxorubicin) in advanced epith…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer [Phase 1]
This update reports that ThermalCore Inc.'s Phase 1 trial of Perfusion Induced Systemic Hyperthermia for terminal ovarian cancer is suspende…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients [Phase 2]
A Phase 2 trial evaluated the feasibility of performing interval debulking surgery via laparoscopy for chemosensitive peritoneal carcinomato…
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Detection of Chlamydia DNA by Polymerase Chain Reaction in Primary Tubal and Ovarian Cancers Tissues : a Pilot Study
A pilot clinical trial update evaluating whether Chlamydia DNA can be detected by PCR in tissues from primary fallopian tube cancers and ova…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
The document reports the completion of a Phase 2 clinical trial evaluating Karenitecin for persistent or recurrent ovarian epithelial cancer…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial CT-2103 for recurrent or persistent ovarian epithelial cancer or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with or without fosbretabulin tromethamine in recurrent or persistent ovarian epithelial, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer [Phase 2]
Phase II trial evaluating bevacizumab followed by consolidation therapy for advanced ovarian cancer and related tumors; results have been po…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Microarray Analysis for Human Genetic Disease
This clinical trial update notes the completed status of a National Human Genome Research Institute–sponsored microarray analysis study in h…
-
CLINICAL_TRIALS trial_result · 2017-06-15Clinical Trial Update: Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer [Phase 1, Phase 2]
A two-arm Phase 1/2a dose-escalation study of BAX69 in patients with malignant ascites due to refractory ovarian cancer has been terminated …
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer [Phase 2]
A Phase 2 trial conducted by GlaxoSmithKline evaluating a second-line intravenous therapy for recurrent platinum-sensitive ovarian, fallopia…
-
CLINICAL_TRIALS trial_result · 2017-06-07Clinical Trial Update: Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian Cancer [Phase 1]
Phase 1 trial update evaluating the safety and pharmacokinetics of escalating doses of DNIB0600A in participants with non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Assess Bioequivalence of Two Formulations of Doxorubicin Hydrochloride Liposome in Female Patients With Ovarian Cancer [Phase 1]
Phase 1 trial completed evaluating bioequivalence between two formulations of liposomal doxorubicin in female patients with ovarian cancer.